Merger brings value multiplier to patient recruitment stakeholders
GLEN BURNIE, Md., June 28, 2021 /PRNewswire/ — CSSi and Patient Advertising Guru, leading patient recruitment vendors, today announce the merger of the two companies, bringing together two best-in-class providers to better serve the recruitment needs of sponsors, CROs, and sites in the pharmaceutical industry.
The company will combine Patient Advertising Guru’s expertise in advertising planning and placement for clinical trial recruitment with CSSi’s unmatched global patient recruitment and retention services. Together, their complementary service offerings will maximize the investments sponsors, CROs, and sites make towards the recruitment process by generating high volume, high quality referrals for clinical studies and converting those referrals into enrollment.
“The merger of these two patient recruitment companies is extremently significant,” said Evan Brett, President of Patient Advertising Guru. “Our ability to generate tremendous referral volume coupled with CSSi’s site support services will transform us into a referral conversion company that will be a game-changer for our clients.”
“Over the past 16 years, CSSi has prided itself in the team’s ability to follow up with referrals and convert them into consented patients for the clinical trials we support,” said Chris Trizna, CSSi’s President. “Adding Patient Advertising Guru’s solution to recruit patients and generate referrals through their strategically placed advertising to our full-service offerings, we are poised to deliver the best results to our clients and remain leaders in this segment of the pharmaceutical industry.”
For more about CSSi, please visit www.cssienroll.com.
For more information about Patient Advertising Guru, please visit www.patientadvertisingguru.com.